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A B S T R A C T   
Accidental hypothermia is associated with increased risk for arrhythmias. QRS/QTc is proposed as an ECG- 
marker, where decreasing values predict hypothermia-induced ventricular arrhythmias. If reliable it should 
also predict nonappearance of arrhythmias, observed in species like rat that regularly tolerate prolonged 
hypothermia. 
A rat model designed for studying cardiovascular function during cooling, hypothermia and subsequent 
rewarming was chosen due to species-dependent resistance to ventricular arrhythmias. ECG was recorded 
throughout the protocol. 
No ventricular arrhythmias occurred during experiments. QRS/QTc increased throughout the cooling period 
and remained above normothermic baseline until rewarmed. 
Different from the high incidence of hypothermia-induced ventricular arrhythmias in accidental hypothermia 
patients, where QRS/QTc ratio is decreased in moderate hypothermia; hypothermia and rewarming of rats is not 
associated with increased risk for ventricular fibrillation. This resistance to lethal hypothermia-induced ar-
rhythmias was predicted by QRS/QTc.   
1. Introduction 
Hypothermia is defined as a reduction of core-temperature to below 
35 ◦C [17]. The neuroprotective effect of hypothermia is undisputed, but 
it is questioned whether therapeutic hypothermia, with core tempera-
ture reduction below 35 ◦C, should be initiated in comatose survivors of 
cardiac arrest [3]. Current advice is to apply targeted temperature 
management (36-32 ◦C) for neuroprotection in these patients [17]. 
During surgical procedures like reconstructive cardiac surgery, the 
neuroprotective effect of cooling is evident and core temperature is 
occasionally reduced to below 20 ◦C [3]. Similar neuroprotection is 
obvious in victims of accidental hypothermia, where survival after 
several hours of cardiac arrest is reported after core-temperature 
reduction down to 13.7 ◦C [10]. 
Neuroprotective effects of hypothermia are present at temperatures 
where increased risk for arrhythmias and cardiac arrest occur, a well- 
known complication of hypothermia [8]. In humans, changes in elec-
trocardiography (ECG) recordings, including prolongation of 
QT-interval and sinus bradycardia are common at core-temperatures 
above 30 ◦C, during use of mild therapeutic hypothermia. Further 
cooling will increase the risk for induced arrhythmias, including nodal 
rhythms, ventricular extrasystoles, atrio-ventricular blocks and ven-
tricular fibrillation (VF) [8]. The underlying mechanisms causing 
pro-arrhythmic activity in hypothermia, however, are not well known. 
This lack of evidence-based knowledge is reflected by guidelines for 
treating victims of accidental hypothermia, where recommendations for 
prevention and treatment of hypothermia-induced arrhythmias are 
missing [23]. 
Abbreviations: VF, Ventricular fibrillation; VT, Ventricular tachycardia; HR, Heart rate; HCA, Hypothermic cardiac arrest; ECG, Electrocardiography; APD, Action 
potential duration. 
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In a series of recent preclinical experiments, we have investigated the 
pathophysiology of hypothermia-induced VF and cardiac arrest (HCA) 
[6–8]. Our findings show that moderate hypothermia (32-28 ◦C) is 
pro-arrhythmic [6–8]. An underlying depolarisation-repolarisation 
mismatch is apparent in rabbit hearts [6], a species with similar car-
diac electrophysiology to humans. This mismatch was prominent at 
31 ◦C and was associated with a doubled risk for inducing VF [6]. 
Further temperature reduction, towards 20 ◦C and below, appears 
anti-arrhythmic in these experiments [6–8]. Further, we found that a 
novel ECG-marker (QRS/QTc) could predict risk for VF in hypothermic 
rabbit hearts and have advocated that it shows potential in hypothermic 
patients [7]. The utility of this marker was dependent on heart rate 
adjustment to correlate with HCA-risk, different from the iCEB-marker 
for Torsades de Pointes [15]. 
In contrast to rabbits that have cardiac electrophysiology resembling 
humans and are at risk for developing hypothermia-induced VF [6–8, 
12], rats do not regularly develop VF, even during several hours of 
exposure to core temperatures between 15 and 13 ◦C [4,5,24]. This 
arrhythmia-resistance is interesting as it allows us to study development 
of QRS/QTc-values during cooling to severe hypothermia, when VF-risk 
is low. Accordingly, we decided to investigate cardiac electrophysiology 
using our well-established rat model of severe hypothermia (15 ◦C), to 
assess whether QRS/QTc could predict occurrence or absence of spon-
taneous, hypothermia-induced ventricular arrhythmias. 
2. Methods 
2.1. Ethics approval and consent to participate 
Male Wistar rats (n = 6) weighing 270–346 g were used in the 
experiment. The rats (Charles River, Germany) had a microbiological 
status according to the recommendation of the Federation of European 
Laboratory Animal Science Associations. Housing was provided in 
accordance with guidelines for accommodation and care of animals 
(article 5 of European Convention for the Protection of Vertebrate An-
imals used for Experimental and Other Scientific Purposes, Strasbourg, 
18.III.1986). The experimental protocol was approved by the Norwegian 
Animal Research Authority and conducted accordingly. 
2.2. Housing 
The animals were quarantined for 1 week on arrival and housed in a 
conventional SPF facility in Eurostandard Type IV cages (2 rats per cage) 
with wood shavings as bedding (Aspen Bedding, Tapvei, Estonia). 
Housing conditions were controlled with temperature and humidity 
maintained at 21 ± 1 ◦C and 55 ± 5%, respectively, and the lighting on a 
12 h light and 12 h dark cycle. The rats were fed ad libitum with a 
conventional rodent maintenance diet (RM1-E, Special Diet Service, UK) 
and tap water. Polycarbonate Rat Tunnels and aspen gnawing bricks 
(both from Scanbur, Denmark) were provided as environmental 
enrichment. The animals were allowed to acclimatize for a period of one 
week after entering the facility and were under daily health checks 
during the housing period prior to the terminal experiment. 
2.3. Anesthesia 
All experiments were started by introducing anesthesia intraperito-
neally; 55 mg/kg pentobarbital sodium and 50 μg/kg fentanyl, followed 
by a continuous infusion of 7.5 mg/kg/hour pentobarbital sodium and 
50 μg/kg/hour fentanyl through an intravenous line in the right jugular 
vein, extended to the right auricle. The infusion was maintained at all 
hours in normothermic animals. Infusion in hypothermic animals was 
terminated at 30 ◦C during cooling and restarted at the same tempera-
ture during rewarming, due to hypothermia-induced anesthesia and 
reduced drug metabolism. During the experiments, toe pinching was 
used continuously, and blood gasses, respiratory rate and heart rate 
monitored closely to ensure that the animals were provided with suffi-
cient anesthesia and analgesia. If any signs of stress were found, anes-
thesia and analgesia was increased through the intravenous line. After 
rewarming, animals were euthanized by a bolus dose of pentobarbital 
sodium and fentanyl through the intravenous line. 
2.4. Respiratory support 
Animals were placed on the operating table in a supine position. The 
trachea was opened, and a tracheal tube inserted. All animals had 
spontaneous and sufficient ventilation at core temperatures >20 ◦C. 
Below 20 ◦C, ventilation was achieved by a volume-controlled New 
England rodent ventilator, model 141 (New England Instruments, 
Massachusetts, USA), using room air. Normoventilation was achieved 
through adjusting ventilation in accordance with blood gas analyzes 
from an ABL 800 blood gas analyzer (Radiometer, Denmark). During 
controlled ventilation, the alpha-stat strategy was followed. 
Electrocardiographic variables were recorded using a 3-channel 
Fe136 Animal Bio Amp device (ADInstruments, Dunedin, New Zealand). 
2.5. Core cooling and rewarming 
Animals were cooled and rewarmed using RTE-110 thermo stated 
water bath (Neslab Instruments, New Hampshire, USA) by circulating 
cold or warm water through a U-shaped polyethylene tube, which was 
inserted gently into the lower bowel to avoid harm to the intestine. In 
addition, the double-layered operating table made of hollow aluminum 
was circulated by temperature-adjusted water. Core temperature was 
continuously monitored using a thermocouple wire positioned in the 
lowest part of esophagus, connected to a Thermalert Th-5 thermocouple 
controller (Bailey Instruments, UK). Cooling and rewarming each lasted 
115 ± 48 min and 98 ± 42 min respectively, and the stable hypothermic 
period (15 ◦C) lasted 4 h. Measurements of recorded variables were 
performed at set temperatures (37, 32, 28, 24, 20 and 15 ◦C) during 
cooling and rewarming. During stable hypothermia, variables were 
recorded every hour. The rate of core rewarming was based on clinical 
practice in our university hospital, where fast rewarming has proven 
successful in hypothermic patients after nearly 7 h of hypothermic 
cardiac arrest. 
2.6. Electrocardiographic measurements 
Electrocardiographic variables were recorded using a 3-channel 
Fe136 Animal Bio Amp device (ADInstruments, Dunedin, New Zea-
land). Left ventricular systolic and diastolic duration was obtained using 
a SPR-838 Millar pressure–volume conductance catheter (Millar In-
struments Inc., Texas, USA). The miniaturized 2.0 french pressur-
e–volume conductance catheter allows assessment of in vivo LV 
mechanical function in rats (1). All variables in this study were calcu-
lated using different modules in the LabChart Pro v8.1.3 software 
package (ADInstruments, Dunedin, New Zealand). 
The present model has been used in numerous studies in our lab, and 
the stability of physiological parameters during 4–5 h of normothermic 
control conditions have been properly documented [4,5]. 
2.7. Statistics 
Sample size calculations were performed in MedCalc 7.2 (MedCalc 
Software, Mariakerke, Belgium). Animals served as their own controls, 
with continuous monitoring of cardiac electrophysiology. Changes 
occurring during cooling, stable hypothermia and rewarming respec-
tively were analyzed by One-way repeated measures ANOVA. Dunnett’s 
method was used to compare values during cooling with pre- 
hypothermic baseline, hypothermic values with hypothermic baseline 
and changes occurring during rewarming with values at the end of the 
stable hypothermia period. To assess differences between pre- 
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hypothermic and rewarmed values at 37 ◦C, a paired t-test was used. 
Results are presented as mean ± SEM. Differences were considered 
significant at p < 0.05. 
3. Results 
No ventricular arrhythmias were observed at any temperatures 
during cooling, stable hypothermia, or rewarming in this experiment. 
3.1. Comparison of variables at pre-hypothermic baseline vs. after 
rewarming (37 ◦C) (Table 1) 
Compared to pre-hypothermic values at 37 ◦C, no changes in heart 
rate (HR) or ECG-characteristics, including QRS/QTc, were found at 
37 ◦C after rewarming.. 
3.2. Cooling to 15 ◦C (Figs. 1–3) 
During cooling to 15 ◦C a significant prolongation of all aspects of the 
ECG recording occurred, when compared to baseline values at 37 ◦C. At 
temperatures including 28 ◦C and below, the QT-interval was signifi-
cantly increased (0.07 ± 0.01sec vs. 0.05 ± 0.01sec, p < 0.05). RR (0.23 
± 0.04sec vs. 0.12 ± 0.04sec, p < 0.05), PR (0,07 ± 0.01sec vs. 0.05 ±
0.01sec, p < 0.05), and QRS (0.04 ± 0.01sec vs. 0,03 ± 0.01sec, p <
0.05) intervals where prolonged after cooling to 24 ◦C, while QR time 
(0,05 ± 0.02sec vs. 0,01 ± 0.00sec, p < 0.05) was increased only after 
cooling to 20 ◦C. Consistent with prolongation of the RR interval, HR 
(272 ± 22bpm vs. 448 ± 47bpm, p < 0.05) was significantly reduced 
after cooling to 28 ◦C. 
There was no sign of an initial reduction of QRS/QTc values during 
moderate hypothermia, as they showed a steady increase throughout the 
entire cooling period, with significantly elevated values after cooling to 
24 ◦C (0.35 ± 0.06 s/s vs. 0.22 ± 0.05 s/s, p < 0.05).. 
3.3. Stable hypothermia (4 h, at 15 ◦C) (Figs. 1–3) 
During stable hypothermia, all variables in the ECG-recording 
remained stable except for the PR interval (0,19 ± 0.05sec vs. 0.16 ±
0.06sec, p < 0.05) that increased during the hypothermic period. HR 
remained stable. 
QRS/QTc values remained statistically unchanged during the 4 h 
hypothermia period. 
3.4. Rewarming to 37 ◦C (Figs. 1–3) 
During rewarming from 15 ◦C to 37 ◦C a significant shortening of the 
QR time (0,01 ± 0.00sec vs. 0,05 ± 0.04sec, p < 0.05), QT (0,05 ±
0.01sec vs. 0,14 ± 0.07sec, p < 0.05), QRS (0,03 ± 0.01sec vs. 0,08 ±
0.05sec, p < 0.05) and PR (0,04 ± 0.00sec vs. 0,11 ± 0.02sec, p < 0.05) 
intervals were observed at 24 ◦C, while the RR interval (0,69 ± 0.23sec 
vs. 1,10 ± 0.15sec, p < 0.05) was reduced during rewarming to 20 ◦C. 
HR (165 ± 34bpm vs. 57 ± 9bpm, p < 0.05) increased significantly 
during rewarming to 24 ◦C. 
During rewarming, the QRS/QTc (0.49 ± 0.15 s/s vs. 0.62 ± 0.09 s/s, 
p < 0.05) values decreased rapidly with significantly reduced values 
already after rewarming to 20 ◦C. Similar to cooling, rewarming did not 
give a reduction of QRS/QTc to below baseline, as values remained 
higher than at 37 ◦C until animals were rewarmed. 
4. Discussion 
In the present intact rat study, we find that despite the presence of 
significant changes in cardiac electrophysiology induced by severe hy-
pothermia and rewarming, no ventricular arrhythmias took place. All 
electrophysiological parameters were however normalised after 
rewarming. As predicted by the QRS/QTc ratio values, which remained 
higher than at normothermia throughout the protocol, we found that 
neither cooling, prolonged hypothermia, nor rewarming created sub-
strate(s) for lethal ventricular arrhythmias in our rat model. 
In humans, spontaneous ventricular arrhythmias are common in 
victims of accidental hypothermia [8]. Accordingly, it is interesting to 
assess risk for spontaneous VF, considering the electrophysiological 
differential effects of hypothermia between humans and rats. The 
hypothermia-induced electrophysiological changes, in the presence of 
intact sinus rhythm, as observed in the present experiment, therefore 
gives valuable information of potential translational value. Background 
pathophysiologic mechanisms for hypothermia-induced VF and cardiac 
arrest in patients has been largely unknown [8]. However, recent efforts 
with translational research into this topic have given possible ground-
breaking results [7]. In rabbit, both increased ventricular divergence 
[12] and heterogenic effect of hypothermia on transmural and longi-
tudinal conduction [6] has been documented at 30 ◦C, with increased 
risk for developing VF. Cooling to 30 ◦C also enhanced dispersion of 
epicardial action potential duration (APD), wavebreaks and re-entry, 
associated with increased vulnerability to pacing-induced VF [13]. In 
pigs cooled to 30 ◦C, VF threshold is reduced by 72% [25]. This is also 
found in dogs at 25 ◦C, where VF threshold was reduced compared to at 
37 ◦C [1]. Cardiac vulnerability, however, does seem to be promoted 
further by rewarming. In canine wedge preparations cooled to 26 ◦C, VF 
and ventricular tachycardia (VT) occurred more frequently during 
rewarming than during cooling [19]. In a similar model, hypothermia 
(32 ◦C) caused local re-excitation and development of polymorphic 
VT/VF [11]. In two recent publications, we reported that the QRS/QTc 
ratio could be used as a highly predictable marker of VF threshold in 
rabbits [6,7]. 
Ventricular ectopic activity is documented being increased in pa-
tients treated with therapeutic hypothermia [22], in addition to the 
occurrence of frequent non-sustained VT [20]. However, most studies 
report that sustained ventricular arrhythmias are uncommon [8], with 
some exceptions as by Mirzoyev et al. who documented polymorphic VT 
in 11.7% of therapeutic hypothermia patients [16]. Most cases with VT 
occurred at a core temperature around 34.7 ◦C, and defibrillation was 
necessary in most of these patients. Patients with polymorphic VT were 
hypokalemic and had significantly prolonged QTc interval [16]. Risk for 
VF is dependent of severity of hypothermia and pose a big challenge 
during rewarming. Of 19 accidental hypothermia patients admitted, 
with core temperatures between 17 ◦C–29 ◦C, seven were in VF, while 
two presented with asystole [2]. In a Japanese study of 60 patients, no 
patients with a core temperature above 26 ◦C developed VF [18]. 
Recently we published a report indicating that the QRS/QTc interval 
could be used as a biomarker of risk for hypothermia-induced VF in such 
patients [7]. 
In the present study, we show that rats are largely resistant to 
spontaneous ventricular arrhythmia, induced by hypothermia. Still, rats 
are vulnerable to pacing-induced arrhythmias and several studies of 
normothermic cardiopulmonary resuscitation are carried out in well- 
established rat models of VF [9,14]. The relative different electrophys-
iological effects when cooling rats, compared to hypothermic patients 
Table 1 
Electrocardiographic variables before cooling (37 ◦C) and after rewarming from 
4 h of stable hypothermia (15 ◦C). * Significant (p < 0.05) difference from pre- 
cooling (37 ◦C) baseline.  
ECG and Cycle duration Pre-cooling 37 ◦C Rewarmed 37 ◦C P-value 
QRS/QTc (sec/sec) 0.224 ± 0.020 0.203 ± 0.020 0,34 
QT interval (sec) 0.045 ± 0.003 0.046 ± 0.004 0,88 
QTc interval (sec) 0.136 ± 0.002 0.137 ± 0.001 0,97 
QR time (sec) 0.010 ± 0.001 0.011 ± 0.001 0,47 
QRS interval (sec) 0.029 ± 0.002 0.028 ± 0.003 0,61 
PR interval (sec) 0.046 ± 0.004 0.037 ± 0.002 0,60 
RR interval (sec) 0.123 ± 0.020 0.111 ± 0.010 0,58 
Heart rate (beats/min) 448 ± 13.0 446 ± 18.5 0,99  
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and animal species that have similar electrophysiology to humans, are 
therefore of interest [8]. In the present study on rats, the QRS/QTc ratio 
increased steadily during cooling, remained stable during hypothermia, 
and was normalised during rewarming. Interestingly, when assessing 
human ECG-data (Fig. 4) [8], QRS/QTc values were similar to those in 
rats at normothermia and at severe hypothermia (<24 ◦C). At these 
temperatures the QRS/QTc ratios in humans were found to be higher 
than 0.2, while initial cooling is associated with a reduction of QRS/QTc 
values during moderate and higher temperatures of severe hypothermia 
(32-24 ◦C). Exposure to such core temperatures is highly associated with 
occurrence of ventricular arrhythmias in hypothermic patients [8]. This 
is similar to the relation between temperature and the QRS/QTc ratio 
values in rabbit hearts, where low QRS/QTc values observed during 
moderate hypothermia correlated highly with increased VF-risk (VF 
threshold). In contrast, QRS/QTc values in rat never fell below 0.2, 
corresponding with absence of spontaneous ventricular arrhythmias in 
the present experiment. 
In a recent study, we found that moderate hypothermia presents a 
“vulnerable window” for hypothermia-induced VF and cardiac arrest in 
rabbit hearts [6]. This pro-arrhythmic state was related to slowed car-
diac conduction and repolarisation, whilst ventricular/transmural acti-
vation remained relatively unaffected, producing an acquired long-QT 
syndrome [6]. As transmural conduction is gap-junction dependent, we 
tested the gap-junction uncoupler Heptanol as an anti-arrhythmic 
measure. After administration, risk for VF was normalised and equal 
to in normothermic hearts [6]. 
Hypothermia-induced QT-prolongation is however not species 
dependent [8] or directly associated with increased risk for VF, as shown 
in the present rat model, where animals were resistant to 
hypothermia-induced ventricular arrhythmia despite a five-fold increase 
in QT-time after cooling to 15 ◦C. VF-resistance in rats could be ascribed 
the critical mass hypothesis, saying that fibrillation is only possible in 
hearts that exceed a critical size. This theory is however challenged by 
that burst pacing triggered VF in a majority of Langendorff-perfused 
mouse hearts [26]. Another explanation for this species-dependent dif-
ference could be the relative transmural distance across the ventricular 
Fig. 1. Changes in electrocardiographic variables during cooling (37◦C–15 ◦C), hypothermia (4 h at 15 ◦C) or rewarming (15◦C–37 ◦C). * Significant (p < 0.05) 
difference from pre-cooling (37 ◦C), hypothermic (15 ◦C) or pre-rewarming (15 ◦C) baseline. 
Fig. 2. Changes in heart rate during cooling (37◦C–15 ◦C), hypothermia (4 h at 15 ◦C) or rewarming (15◦C–37 ◦C). * Significant (p < 0.05) difference from pre- 
cooling (37 ◦C), hypothermic (15 ◦C) or pre-rewarming (15 ◦C) baseline. 
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wall, compared to cardiomyocyte dimensions. Despite small heart size 
and short transmural distance in rats, compared to both humans and 
rabbits, cardiomyocyte dimension is comparable across species [21]. 
Thus, in rats, transmural conduction involves conduction across rela-
tively fewer intercellular elements and therefore is less dependent on 
gap junction/intercellular resistance and more dependent on intracel-
lular resistance than larger hearts (e.g. rabbits [6] and humans). 
Therefore, lowered temperature would reduce ventricular/transmural 
conduction and increase QRS time to a greater extent in rats and small 
mammals than larger animals. Our data supports this theory, as hypo-
thermia has immediate effects on ventricular activation (QRS time) and 
repolarisation time (QT), observed through progressive increases in 
QRS/QTc values during cooling. This indicates that despite prolonged 
QTc in the rat, the risk of arrythmias is more correctly predicted by a 
decrease in QRS/QTc ratio. Such reduction is never encountered across 
the complete range of hypothermia temperatures in rat. This is different 
from rabbit and human data (Fig. 4) [7]. Accordingly, we speculate that 
the limited dependence on gap junction activity for transmural con-
duction is the underlying mechanism for resistance to 
hypothermia-induced VF in rats, compared to other species like rabbit 
and hypothermic patients [6–8]. 
According to our present and previous findings, identifying pro- 
arrhythmic activity during hypothermia depends on the ability to 
detect a heterogenic effect on ventricular/transmural activation, rela-
tive to cardiac conduction and repolarisation [6–8]. Therefore, it is not 
possible to predict the vulnerable window by assessing QT-time alone. 
Risk for hypothermia-induced arrhythmias rather seems to be associated 
with an exaggerated shortening of depolarisation timings (QRS) relative 
to repolarisation time corrected for RR-interval (QTc), namely 
QRS/QTc. From the present and previous translational studies [6–8], we 
propose that 0.2 defines the upper limit of the vulnerable window, as 
measured by QRS/QTc. 
5. Conclusion 
Different from the high incidence of hypothermia-induced ventric-
ular arrhythmias in accidental hypothermia patients, severe hypother-
mia (4 h at 15 ◦C), and rewarming of rats is not associated with increased 
risk for ventricular fibrillation. This resistance to lethal hypothermia- 
induced arrhythmias in rats can be predicted by use of a novel on-line 
ECG-marker; the QRS/QTc ratio. 
Sources of funding 
This work was supported by a grant from the Northern Norwegian 
Health Authority [HNF1337-17]. The funders had no role in study 
design, data collection and analysis, decision to publish, or preparation 
of the manuscript. 
Availability of data and materials 
The datasets generated during and/or analyzed during the current 
study are available from the corresponding author on request. 
Disclosures of potential conflict of interest. 
The authors declare that they have no conflict of interest. 
Fig. 3. Changes in QRS/QTc values during cooling (37◦C–15 ◦C), hypothermia (4 h at 15 ◦C) or rewarming (15◦C–37 ◦C). * Significant (p < 0.05) difference from 
pre-cooling (37 ◦C), hypothermic (15 ◦C) or pre-rewarming (15 ◦C) baseline. 
Fig. 4. *QRS/QTc values in rats from the present experiment, compared to 
recently published human data from our group [4,6]. Rat QRS/QTc values show 
a steady increase during cooling to severe hypothermia, while values in humans 
are reduced in moderate hypothermia. Low QRS/QTc values could be associ-
ated with increased risk for ventricular fibrillation in hypothermic patients [6]. 
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